{
  "id": 13883809,
  "title": "Dong-A ST Launches Darbecron in UAE",
  "url": "https://urgent.news/2026/10/12/dong-a-st-launches-darbecron-in-uae",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-12T05:48:06.000Z",
  "source": {
    "name": "BusinessKorea",
    "slug": "businesskorea",
    "url": "https://www.businesskorea.co.kr/news/articleView.html?idxno=278597"
  },
  "original_language": "en",
  "account": null,
  "summary": "'Darbecron (project name DA-3880),' a second-generation anemia treatment biosimilar developed by Dong-A ST, has been officially launched in the United Arab Emirates (UAE) market.Dong-A ST announced on Oct. 12 local time that it launched Darbecron, a darbepoetin alfa-based biosimilar, in the UAE. Pre",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}